US2011112150A2PendingUtilityA2
Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
Est. expirySep 27, 2016(expired)· nominal 20-yr term from priority
A61P 17/00A61P 17/08A61K 8/4926A61Q 5/006A61Q 5/02A61Q 19/00A61K 31/4412
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis.
Claims
exact text as granted — not AI-modified1 - 13 . (canceled)
14 . A method of treating seborrheic dermatitis comprising administering to a human seborrheic dermatitis patient an amount effective for the treatment of seborrheic dermatitis of a composition comprising only one active ingredient, the active ingredient consisting of ciclopirox and at least one surfactant chosen from anionic surfactants, cationic surfactants, nonionic surfactants, and amphoteric surfactants; wherein the composition has a pH ranging from about 4.5 to about 6.5; and wherein the composition is a single composition.
15 . A method of treating seborrheic dermatitis as claimed in claim 14 in which the composition further comprises at least one additional surfactant chosen from anionic, cationic, nonionic, and amphoteric surfactants.
16 . A method of treating seborrheic dermatitis comprising administering to a human seborrheic dermatitis patient an amount effective for the treatment of seborrheic dermatitis of a composition comprising only one active ingredient, the active ingredient consisting of ciclopirox and at least one surfactant chosen from anionic surfactants, cationic surfactants, nonionic surfactants, and amphoteric surfactants; wherein the composition has a pH ranging from about 4.5 to about 6.5; and wherein the composition is a single composition, which is a shampoo.
17 . A method of treating seborrheic dermatitis as claimed in claim 16 in which the composition further comprises at least one additional surfactant chosen from anionic, cationic, nonionic, and amphoteric surfactants.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.